Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Emisphere Technologies begins phase II trial with oral heparin

June 1, 1998

Integrilin launched in first market today

June 1, 1998

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

U.S. market introduction announced for Plavix

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...